CONCORD DRUGS
Back to Balance Sheet
|
CONCORD DRUGS Last 5 Year Secured Loans History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Secured Loans | ₹1.32 Cr | ₹0.65 Cr | ₹1.91 Cr | ₹1.70 Cr |
What is the latest Secured Loans ratio of CONCORD DRUGS ?
| Year | Secured Loans |
|---|---|
| Mar2025 | ₹1.32 Cr |
| Mar2024 | ₹0.65 Cr |
| Mar2023 | ₹1.91 Cr |
| Mar2022 | ₹1.70 Cr |
How is Secured Loans of CONCORD DRUGS Trending?
| Years | Secured Loans | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.32 Cr | 105.27 | |
| Mar2024 | ₹0.65 Cr | -66.25 | |
| Mar2023 | ₹1.91 Cr | 12.74 | |
| Mar2022 | ₹1.70 Cr | - | |
Compare Secured Loans of peers of CONCORD DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD DRUGS | ₹94.0 Cr | -2.4% | -5.5% | 23.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
CONCORD DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD DRUGS | -2.4% |
-5.5% |
23.3% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses